Glaucoma Market
Report ID: SQMIG35A2274
Glaucoma Market Size, Share, Growth Analysis, By Type(primary open-angle glaucoma (POAG), angle-closure glaucoma (ACG), normal-tension glaucoma (NTG), and secondary glaucoma), By Application(Pharmaceuticals, Surgery, and Devices), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2274 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
64
|Figures:
75
Glaucoma Market Insights
Global Glaucoma Market size was valued at USD 7.8 billion in 2022 and is poised to grow from USD 8.24 billion in 2023 to USD 12.74 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).
The global glaucoma market is witnessing steady growth driven by various factors. One of the key drivers is the increasing prevalence of glaucoma, a chronic eye condition that leads to progressive vision loss if left untreated. The rising geriatric population and the growing incidence of chronic eye diseases contribute to the market growth.
Technological advancements in diagnostics and treatment options, such as minimally invasive surgeries and laser therapies, are also propelling market growth.
However, challenges such as the high cost of treatment and limited access to healthcare in certain regions hinder market expansion. Additionally, the market is characterized by intense competition among key players, leading to ongoing research and development efforts to develop innovative and effective glaucoma management solutions.
Overall, the global glaucoma market is expected to continue growing as awareness, early diagnosis, and advanced treatment options improve.
US Glaucoma Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Glaucoma Market Segmental Analysis
The global glaucoma market is segmented by type, application, and region. Based on type, the market can be segmented into primary open-angle glaucoma (POAG), angle-closure glaucoma (ACG), normal-tension glaucoma (NTG), and secondary glaucoma. Based on application, the market is segmented into pharmaceuticals, surgery, and devices. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Type
The dominant sub-segment in the Type category is Primary Open-Angle Glaucoma (POAG). It is the most prevalent form of glaucoma and is characterized by gradual and painless vision loss. POAG occurs when the drainage angle in the eye becomes partially blocked, leading to increased intraocular pressure and optic nerve damage. This type of glaucoma often progresses slowly and is typically associated with aging.
The fastest-growing sub-segment in the Type category is Angle-Closure Glaucoma (ACG). ACG is characterized by a sudden and severe increase in intraocular pressure due to the blockage of the drainage angle in the eye. It is considered an emergency condition that requires immediate medical attention. ACG can cause rapid vision loss and severe symptoms such as eye pain, headache, and nausea. The increasing awareness of ACG, advancements in diagnostic techniques, and improved treatment options contribute to the growth of this sub-segment.
Analysis by Application
The dominant sub-segment in the Application category is Pharmaceuticals. Medications in the form of eye drops or oral medications are widely used for managing and treating glaucoma. These pharmaceutical interventions aim to lower intraocular pressure (IOP) to prevent or slow down the progression of the disease. Pharmaceutical treatments often include prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, and alpha-adrenergic agonists.
The fastest-growing sub-segment in the Application category is Surgery. When pharmaceutical treatments are insufficient or ineffective, surgical interventions may be necessary. Surgical procedures for glaucoma include trabeculectomy, glaucoma drainage implants, laser trabeculoplasty, and minimally invasive glaucoma surgery (MIGS). The increasing adoption of advanced surgical techniques and devices, along with advancements in technology, contribute to the growth of this sub-segment.
To get detailed analysis on other segments, Request For Free Sample Report
Glaucoma Market Regional Insights
One dominant region in the global glaucoma market is North America. This region has a well-established healthcare infrastructure, advanced medical technologies, and a high prevalence of glaucoma. The presence of key market players, strong research and development activities, and government initiatives to raise awareness about eye health contribute to the dominance of North America in the glaucoma market. Additionally, favourable reimbursement policies and increasing healthcare expenditure support the growth of the market in this region.
One of the fastest growing regions in the global glaucoma market is the Asia-Pacific region. The region is experiencing rapid economic growth, leading to increased healthcare spending and improved access to healthcare services. The rising geriatric population and changing lifestyle patterns contribute to the high prevalence of glaucoma in this region. Moreover, increasing awareness about eye health, advancements in healthcare infrastructure, and the availability of innovative treatment options drive the growth of the glaucoma market in the Asia-Pacific region. Government initiatives aimed at preventing and treating eye diseases also play a significant role in the market's expansion in this region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Glaucoma Market Dynamics
Drivers
Increasing Prevalence Of Glaucoma Worldwide
- One key driver of the global glaucoma market is the increasing prevalence of glaucoma worldwide. The aging population and the rising incidence of chronic diseases, such as diabetes and hypertension, contribute to the growing number of glaucoma cases. As a leading cause of irreversible blindness, the need for early detection, diagnosis, and treatment of glaucoma has become paramount. This drives the demand for innovative glaucoma management solutions, including advanced diagnostic tools, medications, and surgical interventions.
Restraints
Limited Awareness And Lack Of Routine Screening For Glaucoma
- One restraint of the global glaucoma market is the limited awareness and lack of routine screening for glaucoma in many regions. Glaucoma is often asymptomatic in the early stages, making it challenging to diagnose without regular eye examinations. Lack of awareness among individuals and healthcare professionals can result in delayed diagnosis and treatment, leading to irreversible vision loss. In addition, the high cost associated with glaucoma management, including medications, surgeries, and long-term follow-up care, can pose a barrier to access for patients, particularly in low-income and middle-income countries.
Request Free Customization of this report to help us to meet your business objectives.
Glaucoma Market Competitive Landscape
The global Glaucoma market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Glaucoma. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
Top Player’s Company Profiles
- Alcon, Inc. (Switzerland)
- Allergan plc (Ireland)
- Bausch Health Companies Inc. (Canada)
- Carl Zeiss Meditec AG (Germany)
- Ellex Medical Lasers Limited (Australia)
- Glaukos Corporation (United States)
- Haag-Streit Holding AG (Switzerland)
- Heidelberg Engineering GmbH (Germany)
- Lumenis Ltd. (Israel)
- Nidek Co., Ltd. (Japan)
- Novartis AG (Switzerland)
- Optovue, Inc. (United States)
- Santen Pharmaceutical Co., Ltd. (Japan)
- Topcon Corporation (Japan)
- Iridex Corporation (United States)
- Ziemer Group AG (Switzerland)
- Topcon Medical Systems, Inc. (United States)
- Kowa Company, Ltd. (Japan)
- New World Medical, Inc. (United States)
- Reichert, Inc. (United States)
Recent Developments
-
In March 2024, Glaucoma Research Foundation (GRF) announced a total of $2.5 million in annual research grants to support innovative research to cure glaucoma and restore vision. Grants were awarded to 18 investigators at prominent universities in the United States, Nigeria, and Hong Kong.
-
In December 2023, iSTAR Medical introduced its MINIject device for the treatment of patients with glaucoma, in the Netherlands.
-
In October 2023, Stuart Therapeutics and Glaukos signed a licence agreement for the former’s ST-113 drug candidate for neuroprotection in glaucoma.
Glaucoma Key Market Trends
- One key market trend in the global glaucoma market is the increasing adoption of advanced diagnostic technologies and treatment options. Glaucoma, a progressive eye disease that can lead to irreversible vision loss, requires early detection and management to prevent further damage. As a result, there is a growing emphasis on early diagnosis, regular screenings, and advanced imaging techniques for accurate and timely detection of glaucoma. Advanced diagnostic technologies such as optical coherence tomography (OCT), visual field testing, and tonometry are playing a crucial role in improving the diagnosis and monitoring of glaucoma.
Glaucoma Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global glaucoma market is witnessing significant growth due to various factors such as the increasing prevalence of glaucoma, rising aging population, and advancements in diagnostic and treatment options. Glaucoma is a chronic eye disease that can lead to irreversible vision loss if not managed properly. The market is driven by the growing awareness about the importance of regular eye examinations and early detection of glaucoma. Additionally, the development of innovative therapies and surgical interventions, along with the availability of effective medications, is contributing to the market's expansion. However, challenges such as the high cost of treatment and the lack of awareness in certain regions pose restraints to market growth. Overall, the global glaucoma market is expected to continue growing as the demand for improved glaucoma management options increases.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 7.8 billion |
| Market size value in 2031 | USD 12.74 billion |
| Growth Rate | 5.6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Glaucoma Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Glaucoma Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Glaucoma Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Glaucoma Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Glaucoma Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Glaucoma Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
